Avricore Health Inc provides healthcare technology and innovations in the community pharmacy market.
The heath innovator provides point-of-care technology to pharmacists and healthcare experts and claims to revolutionize the healthcare experience of patients.
The company claims that due to reduced medical training of the pharmacists overtime has caused inflation and poor health outcomes as their role in the healthcare community has been reduced to retailers.
Avicore aims at providing a solution to the problem by offering innovative solutions not just in products but in services as well.
The Canadian company provides digitized health data and claims to create an income stream by distributing its systems and associated supplies. It also generates a revenue stream from conducting tests, de-identified real-time health data and software.
The Canadian firm claims to generate most of its income is generated from the HealthTab™+ RASTR Network. Through these platforms, the company provides engaged in equipment leasing, data, consumables, screening Tests, and API integration software.
As of mid-2021, the company is in the commercialization stage and has tested and developed its technology within the pharmacy industry of Canada.
The Canadian firm aims at becoming a leader in the market of point-of-care testing, direct-to-consumer screening, real-time data capture and reporting, real-world evaluations and clinical trials.
The firm uses devices like Abbott Afinion 2 and Abaxis Piccolo to create test results. The HealthTab™ disseminates the results in real time to patients, their healthcare team, or any research specialists.
Amid the pandemic, the company diversified its product portfolio and provided hand sanitizers.
In 2020-2021, the company announced an integration plan with Abbott Diagnostics to combine HealthTab and Afinion 2 blood chemistry analyzer. Avricore’s system includes blood chemistry analyzer, consumer facing touchscreen and software with end-to-end and back-end interfaces. These systems generate and deliver up to 21 results and the data can be shared with sponsors and researchers anonymously.
Avricore also claims to have agreements with healthcare companies such as Clinart MENA, Ontario Pharmacist Association, Ipact, Abott, Abaxis, and Shoppers Drug Mart to offer testing capabilities, real-world evaluation platform.
Avricore Health Inc is listed on the TSX Venture Exchange under the symbol of ‘AVCR’.